These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 35955599)

  • 1. An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects.
    Egbujor MC; Buttari B; Profumo E; Telkoparan-Akillilar P; Saso L
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones.
    de Freitas Silva M; Pruccoli L; Morroni F; Sita G; Seghetti F; Viegas C; Tarozzi A
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30037040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, evaluation, and metabolism of novel [6]-shogaol derivatives as potent Nrf2 activators.
    Zhu Y; Wang P; Zhao Y; Yang C; Clark A; Leung T; Chen X; Sang S
    Free Radic Biol Med; 2016 Jun; 95():243-54. PubMed ID: 27021962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sofalcone, a gastroprotective drug, covalently binds to KEAP1 to activate Nrf2 resulting in anti-colitic activity.
    Kim W; Lee H; Kim S; Joo S; Jeong S; Yoo JW; Jung Y
    Eur J Pharmacol; 2019 Dec; 865():172722. PubMed ID: 31614142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease.
    Geertsema S; Bourgonje AR; Fagundes RR; Gacesa R; Weersma RK; van Goor H; Mann GE; Dijkstra G; Faber KN
    Trends Mol Med; 2023 Oct; 29(10):830-842. PubMed ID: 37558549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenothiazines: Nrf2 activation and antioxidant effects.
    Egbujor MC; Tucci P; Buttari B; Nwobodo DC; Marini P; Saso L
    J Biochem Mol Toxicol; 2024 Mar; 38(3):e23661. PubMed ID: 38369721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia.
    Wu RP; Hayashi T; Cottam HB; Jin G; Yao S; Wu CC; Rosenbach MD; Corr M; Schwab RB; Carson DA
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7479-84. PubMed ID: 20368435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
    Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
    Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oxidative stress in pathophysiology of rheumatoid arthritis: insights into NRF2-KEAP1 signalling.
    Kaur G; Sharma A; Bhatnagar A
    Autoimmunity; 2021 Nov; 54(7):385-397. PubMed ID: 34415206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Nrf2 signaling pathway by natural and synthetic chalcones: a therapeutic road map for oxidative stress.
    Egbujor MC; Saha S; Buttari B; Profumo E; Saso L
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):465-480. PubMed ID: 33691555
    [No Abstract]   [Full Text] [Related]  

  • 12. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
    Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
    Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
    Tocmo R; Parkin K
    Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
    Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
    J Virol; 2020 May; 94(10):. PubMed ID: 32161178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review.
    Singh E; Matada GSP; Abbas N; Dhiwar PS; Ghara A; Das A
    Inflammopharmacology; 2021 Oct; 29(5):1347-1355. PubMed ID: 34373972
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Hu X; Mu L; Zhu L; Chang X; Nie L; Wang L; Li G
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification.
    Shin JW; Chun KS; Kim DH; Kim SJ; Kim SH; Cho NC; Na HK; Surh YJ
    Biochem Pharmacol; 2020 Mar; 173():113820. PubMed ID: 31972171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginnalin A Binds to the Subpockets of Keap1 Kelch Domain To Activate the Nrf2-Regulated Antioxidant Defense System in SH-SY5Y Cells.
    Zhang Z; Peng L; Fu Y; Wang W; Wang P; Zhou F
    ACS Chem Neurosci; 2021 Mar; 12(5):872-882. PubMed ID: 33571414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Kelch-like ECH-associated protein 1 (Keap1)/NF-E2-related factor 2 (Nrf2) pathway through covalent modification of the 2-alkenal group of aliphatic electrophiles in Coriandrum sativum L.
    Abiko Y; Mizokawa M; Kumagai Y
    J Agric Food Chem; 2014 Nov; 62(45):10936-44. PubMed ID: 25307732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy.
    Bono S; Feligioni M; Corbo M
    Mol Neurodegener; 2021 Oct; 16(1):71. PubMed ID: 34663413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.